Reply to Muntean et al. Comment on “Mitteregger et al. A Variant Carbapenem Inactivation Method (CIM) for Acinetobacter baumannii Group with Shortened Time-to-Result: rCIM-A. Pathogens 2022, 11, 482”

Pathogens (Jul 2022)

Affiliations

Dieter Mitteregger: Department of Clinical Microbiology, Laboratory Dr. Kosak, Dr. Reckendorfer and Partner, 1090 Vienna, Austria
Julian Wessely: Department of Clinical Microbiology, Laboratory Dr. Kosak, Dr. Reckendorfer and Partner, 1090 Vienna, Austria
Ivan Barišić: Molecular Diagnostics, Center for Health & Bioressources, AIT Austrian Institute of Technology GmbH, 2444 Vienna, Austria
Branka Bedenić: School of Medicine, University of Zagreb, 10000 Zagreb, Croatia
Dieter Kosak: Department of Clinical Pathology, Laboratory Dr. Kosak, Dr. Reckendorfer and Partner, 1090 Vienna, Austria
Michael Kundi: Center for Public Health, Department of Environmental Health, Medical University of Vienna, 1090 Vienna, Austria

Abstract

We appreciate the interest in our publication and agree that a different acronym for the method would have been better [...]